title: Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study.
abstract: OBJECTIVE
  Real-life glycaemic profiles of healthy individuals are poorly studied. Our aim was to analyse to what extent individuals without diabetes exceed OGTT thresholds for impaired glucose tolerance (IGT) and diabetes.
  
  
  METHODS
  In the A1C-Derived Average Glucose (ADAG) study, 80 participants without diabetes completed an intensive glucose monitoring period of 12 weeks. From these data, we calculated the average 24 h glucose exposure as time spent above different plasma glucose thresholds. We also derived indices of postprandial glucose levels, glucose variability and HbA(1c).
  
  
  RESULTS
  We found that 93% of participants reached glucose concentrations above the IGT threshold of 7.8 mmol/l and spent a median of 26 min/day above this level during continuous glucose monitoring. Eight individuals (10%) spent more than 2 h in the IGT range. They had higher HbA(1c), fasting plasma glucose (FPG), age and BMI than those who did not. Seven participants (9%) reached glucose concentrations above 11.1 mmol/l during monitoring.
  
  
  CONCLUSIONS
  Even though the non-diabetic individuals monitored in the ADAG study were selected on the basis of a very low level of baseline FPG, 10% of these spent a considerable amount of time at glucose levels considered to be 'prediabetic' or indicating IGT. This highlights the fact that exposure to moderately elevated glucose levels remains under-appreciated when individuals are classified on the basis of isolated glucose measurements.
authors.affiliation: Steno Diabetes Center, Niels Steensens Vej 2-4, DK-2820 Gentofte, Denmark. RBrg@steno.dk
authors.forename: R
authors.initials: R
authors.lastname: Borg
authors.forename: J C
authors.initials: JC
authors.lastname: Kuenen
authors.forename: B
authors.initials: B
authors.lastname: Carstensen
authors.forename: H
authors.initials: H
authors.lastname: Zheng
authors.forename: D M
authors.initials: DM
authors.lastname: Nathan
authors.forename: R J
authors.initials: RJ
authors.lastname: Heine
authors.forename: J
authors.initials: J
authors.lastname: Nerup
authors.forename: K
authors.initials: K
authors.lastname: Borch-Johnsen
authors.forename: D R
authors.initials: DR
authors.lastname: Witte
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000032:analysis* / Q000378:metabolism; D005215:Fasting / Q000097:blood; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis* / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D018670:Monitoring, Ambulatory; D012016:Reference Values
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin
references.citation: Diabetes Care. 2006 May;29(5):1130-9
references.pmid: 16644654
references.citation: Diabetes Care. 2003 Nov;26(11):3160-7
references.pmid: 14578255
references.citation: Diabetes Care. 2008 Aug;31(8):1473-8
references.pmid: 18540046
references.citation: Diabetes Technol Ther. 2009 Mar;11(3):159-69
references.pmid: 19267581
references.citation: Diabetes Care. 2009 Jul;32(7):1327-34
references.pmid: 19502545
references.citation: Diabetes Technol Ther. 2008 Jun;10(3):149-59
references.pmid: 18473688